Sustainability
Investors
Products
Research & Development
Company
Contact
Sustainability
ESG
Environment
Social
Investors
Reasons to invest
Share information
News
Reports
Corporate governance
Stock exchange notices
Products
ProGo Bioactive Peptides
OmeGo Salmon Oil
CalGo Calcium Collagen Complex
Shop Branded Products
Research & Development
Our research
All research programs
Studies
Clinical Trial Unit
Company
About us
Our technology
Operations
Management
Board of directors
Contact
Sales
Investor relations
Factories
Management
Type and search
News
Hofseth BioCare ASA successfully completed seed round capital raise in HBC Immunology LLC at $20M valuation for the development of a new prostate cancer co-therapy
New bioavailability study underlines OmeGo®’s ability to unlock the full potential of fresh, whole fish compared to processed 18/12 omega-3 oils
New study uncovers the ability of OmeGo® to temper type 1 inflammation
2022: A year of great achievements for HBC
Hofseth BioCare’s OmeGo® could hold the key to restoring respiratory health and rebalancing the immune system, reveals new study
HBC The Deep Dive: ProGo® under the microscope
Trailblazing Stanford University study highlights promise of ProGo® bioactive peptides in effective gut health support
Food for thought: Spotlight on sustainability at Fi Asia
HBC The Deep Dive: OmeGo® under the microscope
Hofseth BioCare wins 2022 Ringier Technology Innovation Award
ProGo® proven to go beyond nutrition as it earns several new FDA structure function claims
ProGo® bioactive peptides is acknowledged as ‘New Dietary Ingredient’ (NDI) by the FDA
Unique quality approval from US health authorities
Aquaculture fund new significant shareholder in HBC
HBC strengthens capacity on regulatory affairs
New partnership with the world leading pharmacy company Catalent
Healthy dogs have enjoyed more than half a million Brilliant bottles
Breakthrough with Nestle owned clean health supplement brand
Improved distribution in Europe
Long-term collaboration to build global brand and launch consumer health products
DKSH market expansion company to distribute HBC across Asia
New top tier pharma-focused hire to boost sales & marketing
Groundbreaking contract with global ingredient distributor IMCD
Strong approval of HBC products from health authorities
HBC product can claim to support healthy iron levels in the US
New study highlights the potential of OmeGo® as a prophylactic therapy for Asthma and COPD
Global retailer giant to sell HBC-product
Boosts marketing and distribution to Hong Kong and China
Another step from fish to pharma
Green light for COVID-19 study
The Hofseth BioCare approach
Research agreement with Stanford University
Could salmon oil work as treatment of COVID-19 patients?